The Neuromodulation Systems Market is projected to reach $10.29 billion by 2030, at a CAGR of 8.2% from 2023 to 2030. Neuromodulation devices are medical tools used to modify the activity of the nervous system by altering the electrical or chemical signals within the brain and spinal cord. These devices are used to treat a wide range of conditions, such as chronic pain, movement disorders, and depression, by changing how nerve cells communicate and transmit signals.
Neuromodulation devices can be implantable, such as deep brain stimulators or spinal cord stimulators, or non-invasive, such as transcutaneous electrical nerve stimulation (TENS) units. Neuromodulation aims to provide targeted and effective relief to specific areas of the nervous system in a safe and controlled manner. The specific type of neuromodulation device used depends on the target area and the condition being treated.
For example, deep brain stimulation (DBS) devices are used to treat movement disorders, such as Parkinson's disease, by delivering electrical stimulation to specific regions of the brain. On the other hand, spinal cord stimulation (SCS) devices are used to relieve chronic pain by delivering electrical stimulation to the spinal cord.
The high prevalence of neurological disorders and nerve injuries, advancements in neuromodulation & neurostimulation technologies, and expanding applications of neuromodulator systems are the factors driving the growth of this market. Furthermore, emerging economies and the increasing demand for non-invasive devices are expected to offer significant growth opportunities for market expansion. However, the shortage of skilled healthcare professionals and regulatory barriers and recall of neuromodulator systems pose a major challenge to the growth of the neuromodulation systems market.
The rising prevalence of neurological disorders and nerve injuries is one of the factors driving the growth of the neuromodulation device market. According to the United Nations data updated in 2020, approximately 1 billion of the world’s population suffer from neurological disorders. According to Parkinson's Foundation, in the U.S., almost 90,000 people are diagnosed with Parkinson's every year. The number of people with Parkinson's is expected to reach 1.2 million by 2030. Neurological disorders, such as Parkinson's disease and epilepsy, can significantly impact an individual's quality of life, resulting in a high degree of disability. In addition, nerve injuries, such as spinal cord injuries, peripheral nerve injuries, and traumatic brain injuries, can also result in chronic pain and decreased mobility.
Traditionally, these conditions have been treated with medications, physical therapy, or surgery. However, these treatments are not always effective and can result in significant side effects. Neuromodulation devices offer a minimally invasive alternative for treating these conditions and have shown promising results in managing symptoms and improving function. The growth in the geriatric population drives the incidence rate of neurological disorders and nerve injuries, subsequently driving the demand for neuromodulation systems.
Click here to: Get a Free Sample Copy of this report
Emerging Economies in Asia-Pacific and Latin America Offer Significant Opportunities for the Market’s Growth
Emerging economies, such as India, China, and Brazil, have a large and growing population of individuals with neurological disorders and nerve injuries. According to Indian Stroke Association (ISA), the prevalence of stroke is rising in India, with nearly 1.8 million new cases reported annually. Stroke, headache disorders, and epilepsy are the leading contributors to neurological disorders burden in India.
These economies are also experiencing a significant increase in the aging population, which is a risk factor for many neurological conditions. Thus, there is a growing focus on developing and introducing neuromodulation devices, developing local manufacturing capabilities, introducing new and innovative devices, and establishing distribution and service networks in emerging economies to meet the growing demand for effective treatments for these conditions. Efforts are also underway to increase patient awareness and access to these devices in emerging economies by expanding public and private healthcare systems and educating and training healthcare professionals.
Based on type, in 2023, the internal neuromodulation segment is expected to account for the largest share
The factors contributing to the large market share of this segment are the growing number of people with various conditions such as depression, chronic pain, and heart-related diseases. Internal neuromodulation devices are more effective than external devices as they can directly stimulate the target neural circuits, leading to better outcomes for patients. These devices are convenient for long-term use, can be customized according to patient needs, and increases patient compliance. The internal stimulation segment is further subsegmented into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electrical stimulation. In 2023, the spinal cord stimulation segment is expected to account for the largest share of the market.
North America Expected to be the Largest Regional Market in 2023
North America’s major market share is attributed to the high prevalence of neurological disorders, availability of advanced treatment options, well-established healthcare system, significant investments in healthcare, and the growth in the geriatric population. The region has a high prevalence of neurological disorders, such as chronic pain, depression, Parkinson's disease, and epilepsy, driving demand for effective treatments, including neuromodulation devices.
Furthermore, North America's well-developed healthcare system enables access to advanced treatment options, including neuromodulation devices. This has helped to increase patient awareness and access to these devices. Major players operating in the field of neuromodulation systems are from the U.S. Additionally, North America’s well-established healthcare system enables the development, introduction, and widespread adoption of advanced medical technologies, including neuromodulation devices. Also, the growth in the aging population results in the high prevalence of neurological conditions, which drives demand for effective treatments, including neuromodulation systems.
Key Players
The report includes a competitive landscape based on an extensive assessment of the key strategic growth strategies adopted by leading market players between 2020 and 2022. The key players profiled in the global neuromodulation systems market report include LivaNova PLC (U.K.), Nevro Corp. (U.S.), Medtronic plc (Ireland), Abbott Laboratories (U.S.), NeuroSigma, Inc. (U.S.), Neuronetics, Inc. (U.S.), NeuroPace, Inc. (U.S.), Bioventus Inc. (U.S.), MicroTransponder, Inc. (U.S.), Soterix Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), Synapse Biomedical Inc. (U.S.), and Aleva Neurotherapeutics SA (Switzerland).
Scope of the Report:
Neuromodulation Systems Market, by Type
Note: (Other SCS Applications include heart pain (angina), injuries to the spinal cord, nerve-related pain, peripheral vascular disease, and complex regional pain syndrome)
(Other DBS Applications include Dystonia and obsessive-compulsive disorder (OCD) or Tourette disorder)
(Other VNS Applications include stroke and migraine)
(Other TMS Applications include anxiety and generalized anxiety disorder (GAD))
(Other TENS Applications include acute pain and chronic pain)
Neuromodulation Systems Market, by Geography
Key questions answered in the report:
This study offers a detailed assessment of the neuromodulation systems market, including the market sizes & forecasts for various segmentation such as type and geography. This report also involves the value analysis of various segments and subsegments of neuromodulation systems at the regional and country levels.
The global neuromodulation systems market is projected to reach $10.29 billion by 2030, at a CAGR of 8.2% during the forecast period.
Based on type, in 2023, the spinal cord stimulation segment is expected to account for the largest market share due to its increased adoption for treating and managing chronic pain and nerve pain.
The growth of this market is mainly attributed to the rising prevalence of neurological disorders and nerve injuries, increasing awareness about neuromodulation & neurostimulation technologies, and expanding applications of neuromodulator systems. Moreover, emerging economies in Asia-Pacific and Latin America and the increasing demand for non-invasive devices are expected to offer significant market growth opportunities.
The key players profiled in the global neuromodulation systems market report include LivaNova PLC (U.K.), Nevro Corp. (U.S.), Medtronic plc (Ireland), Abbott Laboratories (U.S.), NeuroSigma, Inc. (U.S.), Neuronetics, Inc. (U.S.), NeuroPace, Inc. (U.S.), Bioventus Inc. (U.S.), MicroTransponder, Inc. (U.S.), Soterix Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), Synapse Biomedical Inc. (U.S.), and Aleva Neurotherapeutics SA (Switzerland).
Emerging economies in the Asia-Pacific and Latin America region are projected to offer significant growth opportunities to the market players due to an increase in the aging population, which is a risk factor for many neurological conditions and the growing focus on developing and promoting the adoption of neuromodulation devices.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for this Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Rising Prevalence of Neurological Disorders and Nerve Injuries
4.2.2. Rising Focus on Neuromodulation & Neurostimulation Technologies
4.2.3. Expanding Applications of Neuromodulation Systems
4.3. Restraints
4.3.1. Cost Constraints for Neurological Procedures
4.4. Opportunities
4.4.1. Emerging Economies
4.4.2. Increasing Demand for Non-invasive Devices
4.5. Challenges
4.5.1. Shortage of Skilled Professionals
4.5.2. Regulatory Barriers
4.5.3. Recall of Neuromodulator systems
5. Neuromodulation Systems Market, by Type
5.1. Introduction
5.2. Internal Neuromodulation
5.2.1. Spinal Cord Stimulation (SCS), by Application
5.2.1.1. Failed Back Surgery Syndrome (FBSS)
5.2.1.2. Post-surgical pain
5.2.1.3. Arachnoiditis
5.2.1.4. Other SCS Applications
5.2.2. Deep Brain Stimulation (DBS), by Application
5.2.2.1. Parkinson's Disease
5.2.2.2. Essential Tremor
5.2.2.3. Depression
5.2.2.4. Other DBS Applications
5.2.3. Sacral Nerve Stimulation, by Application
5.2.3.1. Urine incontinence
5.2.3.2. Fecal incontinence
5.2.4. Vagus Nerve Stimulation (VNS), by Application
5.2.4.1. Epilepsy
5.2.4.2. Depression
5.2.4.3. Other VNS Applications
5.2.5. Gastric Electrical Stimulation, by Application
5.2.5.1. Gastroparesis
5.2.5.2. Obesity
5.3. External Neuromodulation
5.3.1. Transcranial Magnetic Stimulation (TMS), by Application
5.3.1.1. Psychiatry
5.3.1.2. Neurology
5.3.1.3. Pediatry
5.3.1.4. Other TMS Applications
5.3.2. Transcutaneous Electrical Nerve Stimulation (TENS)
5.3.2.1. Depression
5.3.2.2. Other TENS Applications
5.3.3. Respiratory Electrical Stimulation
6. Neuromodulation Systems Market, by Geography
6.1. Introduction
6.2. North America
6.2.1. U.S.
6.2.2. Canada
6.3. Europe
6.3.1. Germany
6.3.2. France
6.3.3. U.K.
6.3.4. Italy
6.3.5. Spain
6.3.6. Rest of Europe (RoE)
6.4. Asia-Pacific
6.4.1. Japan
6.4.2. China
6.4.3. India
6.4.4. Rest of Asia-Pacific (RoAPAC)
6.5. Latin America
6.5.1. Brazil
6.5.2. Mexico
6.5.3. Rest of Latin America
6.6. Middle East & Africa
7. Competitive Landscape
7.1. Introduction
7.2. Key Growth Strategies
7.3. Competitive Dashboard
7.3.1. Industry Leaders
7.3.2. Market Differentiators
7.3.3. Vanguards
7.3.4. Emerging Companies
7.4. Competitive Benchmarking
7.5. Market Share Analysis (2022)
8. Company Profiles (Business Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)
8.1. LivaNova PLC
8.2. Nevro Corp.
8.3. Medtronic plc
8.4. Abbott Laboratories
8.5. NeuroSigma, Inc.
8.6. Neuronetics, Inc.
8.7. NeuroPace, Inc.
8.8. Bioventus Inc.
8.9. MicroTransponder, Inc.
8.10. Soterix Medical, Inc.
8.11. Boston Scientific Corporation
8.12. Synapse Biomedical Inc.
8.13. Aleva Neurotherapeutics SA
9. Appendix
9.1. Questionnaire
9.2. Available Customization
List of Tables
Table 1 Global Neuromodulation Systems Market: Impact Analysis of Market Drivers (2023–2030)
Table 2 Global Neuromodulation Systems Market: Impact Analysis of Market Restraints (2023–2030)
Table 3 Global Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 4 Global Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 5 Global Internal Neuromodulation Systems Market Size, by Country/Region, 2021–2030 (USD Million)
Table 6 Global Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 7 Global Spinal Cord Stimulation Market Size, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Spinal Cord Stimulation Market Size for Failed Back Surgery Syndrome, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Spinal Cord Stimulation Market Size for Post-surgical Pain, by Country/Region, 2021–2030 (USD Million)
Table 10 Global Spinal Cord Stimulation Market Size for Arachnoiditis, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Spinal Cord Stimulation Market Size for Other SCS Applications, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 13 Global Deep Brain Stimulation Market Size, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Deep Brain Stimulation Market Size for Parkinson's Disease, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Deep Brain Stimulation Market Size for Essential Tremor, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Deep Brain Stimulation Market Size for Depression, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Deep Brain Stimulation Market Size for Other DBS Applications, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 19 Global Sacral Nerve Stimulation Market Size, by Country/Region, 2021–2030 (USD Million)
Table 20 Global Sacral Nerve Stimulation Market Size for Urine incontinence, by Country/Region, 2021–2030 (USD Million)
Table 21 Global Sacral Nerve Stimulation Market Size for Fecal incontinence, by Country/Region, 2021–2030 (USD Million)
Table 22 Global Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 23 Global Vagus Nerve Stimulation Market Size, by Country/Region, 2021–2030 (USD Million)
Table 24 Global Vagus Nerve Stimulation Market Size for Epilepsy, by Country/Region, 2021–2030 (USD Million)
Table 25 Global Vagus Nerve Stimulation Market Size for Depression, by Country/Region, 2021–2030 (USD Million)
Table 26 Global Vagus Nerve Stimulation Market Size for Other VNS Applications, by Country/Region, 2021–2030 (USD Million)
Table 27 Global Gastric Electrical Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 28 Global Gastric Electrical Stimulation Market Size, by Country/Region, 2021–2030 (USD Million)
Table 29 Global Gastric Electrical Stimulation Market Size for Gastroparesis, by Country/Region, 2021–2030 (USD Million)
Table 30 Global Gastric Electrical Stimulation Market Size for Obesity, by Country/Region, 2021–2030 (USD Million)
Table 31 Global External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 32 Global External Neuromodulation Systems Market Size, by Country/Region, 2021–2030 (USD Million)
Table 33 Global Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 34 Global Transcranial Magnetic Stimulation Market Size, by Country/Region, 2021–2030 (USD Million)
Table 35 Global Transcranial Magnetic Stimulation Market Size for Psychiatry, by Country/Region, 2021–2030 (USD Million)
Table 36 Global Transcranial Magnetic Stimulation Market Size for Neurology, by Country/Region, 2021–2030 (USD Million)
Table 37 Global Transcranial Magnetic Stimulation Market Size for Pediatry, by Country/Region, 2021–2030 (USD Million)
Table 38 Global Transcranial Magnetic Stimulation Market Size for Other TMS Applications, by Country/Region, 2021–2030 (USD Million)
Table 39 Global Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 40 Global Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Country/Region, 2021–2030 (USD Million)
Table 41 Global Transcutaneous Electrical Nerve Stimulation Market Size for Depression, by Country/Region, 2021–2030 (USD Million)
Table 42 Global Transcutaneous Electrical Nerve Stimulation Market Size for Other TENS Applications, by Country/Region, 2021–2030 (USD Million)
Table 43 Global Respiratory Electrical Nerve Stimulation Market Size, by Country/Region, 2021–2030 (USD Million)
Table 44 Global Neuromodulation Systems Market Size, by Country/Region, 2021–2030 (USD Million)
Table 45 North America: Neuromodulation Systems Market Size, by Country, 2021–2030 (USD Million)
Table 46 North America: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 47 North America: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 48 North America: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 49 North America: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 50 North America: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 51 North America: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 52 North America: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 53 North America: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 54 North America: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 55 U.S.: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 56 U.S.: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 57 U.S.: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 58 U.S.: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 59 U.S.: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 60 U.S.: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 61 U.S.: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 62 U.S.: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 63 U.S.: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 64 Canada: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 65 Canada: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 66 Canada: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 67 Canada: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 68 Canada: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 69 Canada: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 70 Canada: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 71 Canada: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 72 Canada: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 73 Europe: Neuromodulation Systems Market Size, by Country/Region, 2021–2030 (USD Million)
Table 74 Europe: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 75 Europe: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 76 Europe: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 77 Europe: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 78 Europe: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 79 Europe: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 80 Europe: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 81 Europe: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 82 Europe: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 83 Germany: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 84 Germany: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 85 Germany: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 86 Germany: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 87 Germany: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 88 Germany: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 89 Germany: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 90 Germany: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 91 Germany: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 92 France: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 93 France: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 94 France: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 95 France: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 96 France: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 97 France: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 98 France: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 99 France: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 100 France: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 101 U.K.: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 102 U.K.: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 103 U.K.: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 104 U.K.: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 105 U.K.: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 106 U.K.: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 107 U.K.: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 108 U.K.: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 109 U.K.: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 110 Italy: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 111 Italy: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 112 Italy: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 113 Italy: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 114 Italy: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 115 Italy: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 116 Italy: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 117 Italy: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 118 Italy: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 119 Spain: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 120 Spain: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 121 Spain: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 122 Spain: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 123 Spain: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 124 Spain: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 125 Spain: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 126 Spain: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 127 Spain: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 128 Rest of Europe: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 129 Rest of Europe: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 130 Rest of Europe: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 131 Rest of Europe: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 132 Rest of Europe: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 133 Rest of Europe: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 134 Rest of Europe: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 135 Rest of Europe: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 136 Rest of Europe: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 137 Asia-Pacific: Neuromodulation Systems Market Size, by Country/Region, 2021–2030 (USD Million)
Table 138 Asia-Pacific: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 139 Asia-Pacific: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 140 Asia-Pacific: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 141 Asia-Pacific: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 142 Asia-Pacific: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 143 Asia-Pacific: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 144 Asia-Pacific: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 145 Asia-Pacific: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 146 Asia-Pacific: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 147 China: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 148 China: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 149 China: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 150 China: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 151 China: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 152 China: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 153 China: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 154 China: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 155 China: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 156 Japan: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 157 Japan: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 158 Japan: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 159 Japan: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 160 Japan: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 161 Japan: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 162 Japan: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 163 Japan: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 164 Japan: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 165 India: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 166 India: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 167 India: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 168 India: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 169 India: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 170 India: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 171 India: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 172 India: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 173 India: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 174 Rest of Asia-Pacific: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 175 Rest of Asia-Pacific: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 176 Rest of Asia-Pacific: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 177 Rest of Asia-Pacific: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 178 Rest of Asia-Pacific: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 179 Rest of Asia-Pacific: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 180 Rest of Asia-Pacific: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 181 Rest of Asia-Pacific: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 182 Rest of Asia-Pacific: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 183 Latin America: Neuromodulation Systems Market Size, by Country/Region, 2021–2030 (USD Million)
Table 184 Latin America: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 185 Latin America: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 186 Latin America: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 187 Latin America: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 188 Latin America: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 189 Latin America: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 190 Latin America: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 191 Latin America: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 192 Latin America: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 193 Brazil: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 194 Brazil: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 195 Brazil: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 196 Brazil: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 197 Brazil: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 198 Brazil: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 199 Brazil: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 200 Brazil: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 201 Brazil: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 202 Mexico: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 203 Mexico: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 204 Mexico: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 205 Mexico: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 206 Mexico: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 207 Mexico: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 208 Mexico: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 209 Mexico: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 210 Mexico: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 211 Rest of Latin America: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 212 Rest of Latin America: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 213 Rest of Latin America: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 214 Rest of Latin America: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 215 Rest of Latin America: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 216 Rest of Latin America: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 217 Rest of Latin America: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 218 Rest of Latin America: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 219 Rest of Latin America: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 220 Middle East & Africa: Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 221 Middle East & Africa: Internal Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 222 Middle East & Africa: Spinal Cord Stimulation (SCS) Market Size, by Application, 2021–2030 (USD Million)
Table 223 Middle East & Africa: Deep Brain Stimulation (DBS) Market Size, by Application, 2021–2030 (USD Million)
Table 224 Middle East & Africa: Sacral Nerve Stimulation Market Size, by Application, 2021–2030 (USD Million)
Table 225 Middle East & Africa: Vagus Nerve Stimulation (VNS) Market Size, by Application, 2021–2030 (USD Million)
Table 226 Middle East & Africa: External Neuromodulation Systems Market Size, by Type, 2021–2030 (USD Million)
Table 227 Middle East & Africa: Transcranial Magnetic Stimulation (TMS) Market Size, by Application, 2021–2030 (USD Million)
Table 228 Middle East & Africa: Transcutaneous Electrical Nerve Stimulation (TENS) Market Size, by Application, 2021–2030 (USD Million)
Table 229 Recent Developments, by Company (2020–2022)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Neuromodulation Systems Size, by Type, 2023 Vs. 2030 (USD Million)
Figure 8 Neuromodulation Systems Market, by Region
Figure 9 Market Dynamics
Figure 10 Global Neuromodulation Systems Size, by Type, 2023 Vs. 2030 (USD Million)
Figure 11 Global Neuromodulation Systems Size, by Region, 2023 Vs. 2030 (USD Million)
Figure 12 North America: Neuromodulation Systems Market Snapshot
Figure 13 Europe: Neuromodulation Systems Market Snapshot
Figure 14 Asia-Pacific: Neuromodulation Systems Market Snapshot
Figure 15 Latin America: Neuromodulation Systems Market Snapshot
Figure 16 Recent Developments: Neuromodulation Systems Market (2020–2023)
Figure 17 Competitive Benchmarking: Neuromodulation Systems Market: Based on Type
Figure 18 Competitive Benchmarking: Neuromodulation Systems Market: Based on Geography
Figure 19 Competitive Dashboard: Neuromodulation Systems Market
Figure 20 Market Share Analysis: Neuromodulation Systems Market (2022)
Figure 21 LivaNova PLC: Financial Overview (2022)
Figure 22 Nevro Corp.: Financial Overview (2022)
Figure 23 Medtronic plc: Financial Overview (2022)
Figure 24 Abbott Laboratories: Financial Overview (2022)
Figure 25 Neuronetics, Inc.: Financial Overview (2022)
Figure 26 NeuroPace, Inc.: Financial Overview (2022)
Figure 27 Bioventus Inc.: Financial Overview (2022)
Figure 28 Boston Scientific Corporation: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Aug-2023
Published Date: Jan-2019
Published Date: Dec-2017
